[144] IPG PHOTONICS CORP SEC Filing

Rhea-AI Filing Summary

IPG Photonics (IPGP) filed a Form 144 notice reporting a proposed sale of 27,945 shares of common stock through Stifel Nicolaus & Company, Inc. on 09/18/2025 with an aggregate market value of $2,305,810.00 and 42,219,918 shares outstanding reported on the form.

The securities were acquired as Restricted Stock Units on 03/01/2020 (amount acquired: 55,890 units). Payment for the proposed sale is indicated as cash. The filer states there were no securities sold in the past three months for the account and includes the standard representation regarding material nonpublic information.

Insights

Securities Analyst

TL;DR Routine insider notice of a planned sale of 27,945 shares under Rule 144, documenting acquisition history and broker details.

The Form 144 is a procedural disclosure required when restricted or control securities are proposed to be sold publicly. It lists the broker (Stifel Nicolaus & Company), the amount to be sold (27,945 shares), the acquisition type (restricted stock units acquired 03/01/2020), and the intended sale date (09/18/2025). No sales in the prior three months are reported, which limits near-term selling history in the filing. This filing alone provides transparency on an intended disposition but does not, by itself, indicate material company-level developments.

Corporate Governance Expert

TL;DR Standard compliance filing showing an insider-origin RSU sale through a registered broker; procedural, not a governance event.

The notice includes the required attestation about absence of undisclosed material information and cites the broker and cash payment method. It documents the original grant date and quantity of RSUs (55,890) and specifies the portion proposed for sale (27,945). From a governance perspective, the form demonstrates adherence to disclosure rules and trading protocols but contains no indications of policy change, executive departure, or other governance actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	27945	2305810.00	42219918	09/18/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2020	Restricted Stock Units	Issuer			55890	09/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IPGP's Form 144 report?

The Form 144 reports a proposed sale of 27,945 shares of common stock through Stifel Nicolaus & Company with an aggregate market value of $2,305,810.00 to occur on 09/18/2025.

How were the securities to be sold acquired?

The securities were acquired as Restricted Stock Units on 03/01/2020, totaling 55,890 units at acquisition.

Will the sale proceeds be paid in cash?

Yes. The form indicates the date of payment as 09/18/2025 and the nature of payment as cash.

Does the filing report other recent sales by this person?

No. The Form 144 states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker is handling the proposed sale?

The broker listed is Stifel Nicolaus & Company Inc, located at 501 N Broadway, St. Louis, MO 63102.